Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Burixafor + G-CSF for Stem Cell Mobilization
NCT02104427Phase 2Completed
- Sponsor
- GPCR Therapeutics
- Start
- Feb 2015
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of burixafor in multiple myeloma (MM), non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), sponsored by GPCR Therapeutics. Started Feb 2015; status: completed.
02
Drugs
burixafor
03
Conditions
multiple myeloma (MM)non-Hodgkin lymphoma (NHL)Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT02104427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02104427.